Untreated, these symptoms may contribute to non-adherence with oncologic treatment, which can affect long-term survival. Physical symptoms secondary to depression may result in unnecessary dose adjustments, transfusions, and increased frequency of follow-up, all of which can lead to providers feeling incompetent and overwhelmed.
Join us for this interactive session where we will identify common mental health symptoms experienced by pediatric hematology/oncology patients. We will also illustrate the developmental factors that can influence treatment through a patient video presentation. Then, we will discuss behavioral health interventions and common medications used in the treatment of mental health symptoms, including small group participation to assist in the mastery of using these tools. Furthermore, we will examine methods for integrating mental health services within pediatric hematology/oncology programs including tele-psychiatry and psychological services. Finally, we will identify and manage the challenges of our own emotional responses to treating complex pediatric hematology/oncology patients, including patients with concurrent mental health symptoms.
- It's All GREEK To Me! The NEPENTHE Trial for Relapsed/Refractory Neuroblastoma; Personalized Molecularly Targeted Treatment (200)
- A Sustainable Community Engagement Program Model to Address Hematopoietic Cell Transplantation Education Needs for Patients with Sickle Cell Disease (201)
- Nursing Management for the Successful Application of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy (212)
- Beyond Pain Crises: Acute Complications of Sickle Cell Disease (202)
- The First 6 months: Health Care in the United States under a new President (213)